Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
€36.00
Essentials of Aprezo 30 mg Glenmark Pharmaceuticals Ltd.: what you need to know
Aprezo 30 mg, manufactured by Glenmark Pharmaceuticals Ltd., is primarily known for its active ingredient, Apremilast. This medication is classified as a phosphodiesterase 4 (PDE4) inhibitor, mainly utilized for its anti-inflammatory properties. Aprezo is often prescribed to manage conditions like psoriatic arthritis and plaque psoriasis, helping patients reduce inflammation and improve their quality of life. It is worth noting that Aprezo does not promote significant performance-enhancing effects for athletes.
Effectiveness of Aprezo 30 mg Glenmark Pharmaceuticals Ltd. in sports
While Aprezo 30 mg is not traditionally used in sports, it does offer certain benefits that athletes may find valuable. The anti-inflammatory effect achieved by inhibiting PDE4 can assist in managing chronic inflammation often experienced after intense training sessions. This can indirectly help athletes by reducing discomfort and aiding recovery. However, it is crucial to understand that Aprezo is not aimed at enhancing strength or endurance directly. Its primary role is to assist those who might otherwise struggle with inflammation that could hinder their training.
Recommended dosages and cycles
For medical purposes, Aprezo 30 mg is typically administered as two tablets daily after an initial titration phase. However, for athletes seeking potential anti-inflammatory benefits, a consultation with a health professional is advisable. It is essential to follow a proper dosing schedule to minimize side effects. Using Aprezo without medical advice for sports purposes can lead to unmonitored use and potential risks.
Positive aspects of Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
Aprezo 30 mg offers several advantages for those who may need support in managing inflammation. Its anti-inflammatory properties can lead to enhanced comfort during training, which may allow for more consistent workout routines. Additionally, it has minimal effects on liver function, making it a relatively safe option for most. Unlike many performance-enhancing drugs, which can lead to severe side effects and health risks, Aprezo presents a more balanced alternative focused on recovery rather than enhancement.
Where to buy Aprezo 30 mg Glenmark Pharmaceuticals Ltd. in England?
If you are considering purchasing Aprezo 30 mg Glenmark Pharmaceuticals Ltd., buying from our online store in England is a smart choice. We offer competitive pricing at £36.00 per pack and provide a user-friendly shopping experience. Our store guarantees the authenticity of products and ensures safe delivery to your doorstep. By choosing our online store, you’re not just purchasing a product; you are opting for quality and trustworthiness in your health needs.
| Active substance | Apremilast |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Minimal to no hepatotoxicity reported |
| Lab Test | Monitoring is not typically required for liver enzymes unless under specific medical advice |
| Strength | 30mg |
| Also known as | CC-10004 |
| Blood pressure | No significant effects on blood pressure |
| Trade name | Otezla |
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F) |
| Chemical name | N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide |
| Formula | C22H24N2O7S |
| Substance class | Phosphodiesterase 4 (PDE4) inhibitor |
| Main action | Anti-inflammatory |
| Half-life | Approximately 6-9 hours |
| Dosage (medical) | 30 mg twice daily after initial titration |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response |
| Side effects | Diarrhea, nausea, headache, upper respiratory tract infection, weight loss |
| Use in sports | Not typically used in sports, lacks performance-enhancing properties |
| Manufacturer | Glenmark Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |


Reviews
There are no reviews yet.